You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Meningeal Carcinomatosis

Showing 1 - 25 of 278
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

Not yet recruiting
  • NSCLC Associated With Leptomeningeal Metastases
  • Tislelizumab, pemetrexed
  • (no location specified)
Nov 21, 2023

Leptomeningeal Metastasis Trial in Aarhus (CSI)

Not yet recruiting
  • Leptomeningeal Metastasis
  • CSI
  • Aarhus, Denmark
    Aarhus University Hospital
Feb 28, 2023

NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • (no location specified)
Mar 27, 2023

Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

Not yet recruiting
  • Breast Cancer Metastatic
  • Leptomeningeal Metastasis
  • Tucatinib Oral Tablet
  • +2 more
  • (no location specified)
Mar 23, 2023

Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)

Terminated
  • Breast Cancer Female
  • Leptomeningeal Metastases
  • HER2 BATs
  • Charlottesville, Virginia
    University of Virginia
Dec 15, 2022

Patients With Leptomeningeal Metastases ((LM) Using CNSide

Recruiting
  • Leptomeningeal Metastasis
  • +4 more
  • CNSide
  • Los Angeles, California
    Valkyrie Clinical Trials
Sep 7, 2022

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)

Recruiting
  • Leptomeningeal Metastases
  • Pemetrexed (1)
  • +4 more
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Sep 29, 2022

Leptomeningeal Metastasis Trial in Dallas, San Antonio (186RNL)

Recruiting
  • Leptomeningeal Metastasis
  • Dallas, Texas
  • +1 more
Jul 12, 2022

Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

Recruiting
  • Leptomeningeal Metastasis
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jun 8, 2022

NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)

Recruiting
  • NSCLC
  • +3 more
  • TY-9591 Tablets
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022

Solid Tumor, Solid Tumor, Adult, Leptomeningeal Metastasis Trial in Boston (Pembrolizumab, Lenvatinib)

Recruiting
  • Solid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 22, 2021

Leptomeningeal Metastasis, Solid Tumor, Adult Trial in United Kingdom, United States (radiolabeled DPTA-omburtamab)

Withdrawn
  • Leptomeningeal Metastasis
  • Solid Tumor, Adult
  • radiolabeled DPTA-omburtamab
  • Los Angeles, California
  • +7 more
Jul 12, 2022

NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line

Recruiting
  • NSCLC
  • +2 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 25, 2021

Meningeal Carcinomatosis Trial in Amsterdam (lumbar puncture)

Completed
  • Meningeal Carcinomatosis
  • lumbar puncture
  • Amsterdam, Netherlands
  • +1 more
Jan 19, 2021

Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))

Recruiting
  • Leptomeningeal Metastases
  • Deferoxamine (DFO)
  • Basking Ridge, New Jersey
  • +6 more
Jun 27, 2022

Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)

Recruiting
  • Brain Metastases
  • Leptomeningeal Metastasis
  • GDC-0084
  • whole brain radiation therapy radiation
  • Miami, Florida
  • +9 more
Jan 3, 2023

Leptomeningeal Metastases Trial in United States (Involved-field Photon Radiation Therapy, Proton Craniospinal Irradiation

Active, not recruiting
  • Leptomeningeal Metastases
  • Involved-field Photon Radiation Therapy
  • +3 more
  • Basking Ridge, New Jersey
  • +7 more
Jul 22, 2022

NSCLC, Leptomeningeal Metastasis, EGFR Activating Mutation Trial in Nanchang (Almonertinib, Bevacizumab)

Not yet recruiting
  • NSCLC
  • +2 more
  • Nanchang, Jiangxi, China
    The Second Afiliated Hospital of Nanchang University
Jun 26, 2021

NSCLC, Leptomeningeal Metastases, Brain Metastases Trial in United States (Tesevatinib)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • +2 more
  • Beverly Hills, California
  • +6 more
Mar 7, 2022

Breast Cancer, Leptomeningeal Metastasis Trial in Lille (Cerebrospinal fluid and blood sample collection at the initial

Withdrawn
  • Breast Cancer
  • Leptomeningeal Metastasis
  • Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
  • +2 more
  • Lille, Hauts-de- France, France
  • +1 more
Oct 5, 2021

Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)

Recruiting
  • Leptomeningeal Metastasis
  • Lung Cancer
  • Hebei, Shijiazhuang/hebei, China
  • +1 more
Apr 18, 2021

Neoplastic Meningitis Trial in Houston (Bevacizumab)

Completed
Has Results
  • Neoplastic Meningitis
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 30, 2020

NSCLC With EGFR T790M Mutation, With Brain and/or Leptomeningeal Metastasis, Failed Tyrosine Kinase Inhibitors Trial in Seoul

Active, not recruiting
  • Non-Small Cell Lung Cancer With EGFR T790M Mutation
  • +2 more
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Aug 8, 2021